World-leading data, KOL mapping and impact measurement

Transforming KOL engagement and Medical Affairs impact with world-leading data and Share of Scientific Voice™

Request a demo

As of August 2022, Pharmaspectra became an IQVIA business. This further strengthened and widened the capabilities available to our clients as we joined together our world-leading data and solutions.

Since our full integration into IQVIA is now complete, it will soon be time to retire the Pharmaspectra brand.

Early in 2024, content of the current Pharmaspectra website will transition to to provide an optimized experience and access to the breadth of IQVIA’s solutions.

For now, you can still browse content on the Pharmaspectra website or log in to the platform.

Alternatively, click here to access the relevant page on, where you can also log in to the Pharmaspectra platform.

Superior global data

Whatever the geographical region or therapeutic area, we have the largest collection of meetings abstracts, from international and national congress to local meetings and hospital grand rounds.

  • 22,000

    scientific meetings tracked annually

  • 1.87m

    meeting abstracts uploaded per year 6 x that of other providers

  • 26

    different sources beyond

Our solutions

Superior data and analytics power a set of game-changing solutions that maximize your resources and impact

  • Medical Executives

  • Field Medical

  • Scientific Comms

  • R&D

  • Our data and platforms drive strategy, decision-making and leadership across functions, from R&D to medical and commercial

What our clients say

We work with 18 of the world's top 25 pharmaceutical companies. Here's what they say about us...

  • Pharmaspectra’s data set stands out, but the greatest value comes from their actionable KOL insights and measurement which have made a difference for even my most experienced teams.
    Holly Schachner Former Chief Medical Officer, Allergan Specialty Medicine
  • The breadth and depth of the data that Pharmaspectra provides, allows evidence-based decision-making across all medical functions
    Charles Hugh-Jones CEO Volastra Therapeutics
  • In pediatrics and rare diseases, there are few very relevant experts. Publications inform on experts from a few years ago, but meeting abstracts can help identifications a few months ahead. In this way, Pharmaspectra’s data provides unique support.
    Frank Tennigkeit Pediatric & Rare Disease Development Lead, UCB
  • I am grateful to the Pharmaspectra team for their impressive overview of current and relevant information. Thanks to their proactive conference support, I was able to identify some interesting contributions at diabetes congresses by German KOLs who were not previously known to me.
    Dr. Mussa Arvani Head of Medical Science Liaison, Sanofi
  • Takeda logo


See for yourself

We deliver global data and analytics with tools that are comprehensive, credible and compliant

Request a demo